| Literature DB >> 27927061 |
Hussain Raza1, Qamar Abbas1, Mubashir Hassan1, Seong-Hui Eo1, Zaman Ashraf1, Daeyoung Kim2, Abdul Rehman Phull1, Song Ja Kim1, Sung Kwon Kang2, Sung-Yum Seo1.
Abstract
CONTEXT: Ostericum koreanum (Maxim.) Kitagawa (Apiaceae) roots are traditionally used as an analgesic and antiulcer agent. However, the antiulcer potential of isoimperatorin isolated from O. koreanum has not yet been explored. AIM: To evaluate the antiulcer activity of isoimperatorin isolated from the roots of O. koreanum.Entities:
Keywords: Medicinal plants; molecular docking; type II collagen; urease inhibition
Mesh:
Substances:
Year: 2017 PMID: 27927061 PMCID: PMC6130598 DOI: 10.1080/13880209.2016.1257641
Source DB: PubMed Journal: Pharm Biol ISSN: 1388-0209 Impact factor: 3.503
Figure 1.Chemical structure of isoimperatorin.
Figure 2.Ortep view of the crystal structure of isoimperatorin.
Figure 3.Effect of isoimperatorin on ulcer index for ulcers induced by ethanol, indomethacin, or pylorus ligation. Numbers indicate the % protection with respect to the control groups of different ulcer models. Bars represent the mean ± SEM of each group (n = 5). One-way analysis of variance (ANOVA) was employed and significant differences between control groups and groups treated with isoimperatorin are represented by *p < 0.05 and **p < 0.001. (a) % protection of isoimperatorin in ethanol-induced ulcer model (b) % protection of isoimperatorin in indomethacin induced ulcer model (c) % protection of isoimperatorin in pyloric ligated induced ulcer model
Figure 4.Effect of isoimperatorin treatment on the viability of rabbit articular chondrocytes. Chondrocytes were treated with the indicated concentrations (0.0–737.74 μM) of isoimperatorin for 24 h. Photographs of chondrocytes (A) were taken with a phase-contrast microscope (200× magnification). Cell viability was estimated using the methyl thiazole tetrazolium (MTT) assay. The graphical data (B) are expressed as mean ± standard error of mean.
Figure 5.Effect of isoimperatorin on the dose-dependent expression of type II collagen in primary chondrocytes. After the treatment of chondrocytes with indicated concentrations of isoimperatorin for 24 h, (A) type II collagen expression was detected using Western blot analysis. (B) Isoimperatorin increased the expression of type II collagen in primary chondrocytes in the presence or absence of IL-1β. GAPDH was used as the loading control.
Figure 6.Interactions between isoimperatorin and Jack bean urease (PDB ID 3LA4) at the active site, generated using Discovery studio 2.1.0. The light silver colour shows the backbone of the urease protein in solid ribbon format. Carbon and oxygen atoms of the ligand molecule are shown in green and red, respectively. The interacting residues are shown in blue, while the dotted lines indicate the binding distances (Å).
Chemo-informatic properties of isoimperatorin.
| Chemo-informatics properties | Values |
|---|---|
| Molecular formula | C16H14O4 |
| Molecular weight | 270.27996 |
| Composition | C (71.10%) H (5.22%) O (23.68%) |
| Molar refractivity | 75.01 ± 0.03 cm3 |
| Molar volume | 217.4 ± 3.0 cm3 |
| Parachor | 568.5 ± 6.0 cm3 |
| Index of refraction | 1.606 ± 0.0 |
| Surface tension | 46.7 ± 3.0 dyne/cm |
| Density | 1.242 ± 0.06 g/cm3 |
| Polarizability | 29.73 ± 0.5 10−24 cm3 |
| Monoisotopic mass | 270.089209 Da |
| Number of HBA | 4 |
| Number of HBD | 0 |
| MolLogP | 3.84 |
| MolLogS | 3.00 |
| MolPSA | 36.35 A2 |
| MolVol | 297.81 A3 |
| Number of stereo centres | 0 |
| Drug-Likeness model score | −0.73 |
| Lipinski rule | Yes |
HBA: hydrogen bond acceptor; HBD: hydrogen bond donor.
ADMET properties of isoimperatorin.
| Property | Model name | Predicted values | Units |
|---|---|---|---|
| Absorption | Water solubility | −4.433 | (log mol/L) |
| Caco2 permeability | 1.365 | (log Papp in10−6 cm/s) | |
| Intestinal absorption (human) | 97.293 | (% Absorbed) | |
| Skin permeability | −2.673 | (log Kp) | |
| P-glycoprotein substrate | Yes | (Yes/No) | |
| Distribution | VDss (human) | −0.23 | (log L/kg) |
| Fraction unbound (human) | 0.18 | (Fu) | |
| BBB permeability | 0.117 | (log BB) | |
| CNS permeability | −1.793 | (log PS) | |
| Metabolism | CYP2D6 substrate | No | (Yes/No) |
| CYP1A2 inhibitor | No | (Yes/No) | |
| CYP3A4 inhibitor | Yes | (Yes/No) | |
| Excretion | Total clearance | 0.968 | (log mL/min/kg) |
| Renal OCT2 substrate | No | (Yes/No) | |
| Toxicity | Ames toxicity | No | (Yes/No) |
| Maximum tolerated dose (human) | 0.979 | (log mg/kg/day) | |
| Oral rat acute toxicity (LD50) | 2.229 | (log mg/kg_bw/day) | |
| Hepatotoxicity | No | (Yes/No) | |
| Skin sensitization | No | (Yes/No) |
ADMET: Absorption, Distribution, Metabolism, Excretion and Toxicity.
fu, fraction unbound in plasma.
Log BB, Blood–brain barrier;.
(Log PS), rate of passive diffusion/permeability; brain/plasma equilibration rate.
Energy of docked isoimperatorin and urease complex.
| Docking energy | Kcal/mol |
|---|---|
| Binding energy | −5.70 |
| Ligand efficiency | −0.29 |
| Inhibition constant (μM) | 5.99 |
| Intermolecular energy | −6.59 |
| Vdw_hb_desolve_energy | −6.42 |
| Electrostatic energy | −0.18 |
| Torsional energy | −0.89 |
As measured using AutoDock.
| (I) shedding of epithelium | 10 |
| (II) petechial and frank haemorrhages | 20 |
| (III) one or two ulcers | 30 |
| (IV) more than two ulcers | 40 |
| (V) perforated ulcers | 50 |